attachment
attachment
attachment
attachment
attachment
attachment

A women had got herpes following which she was prescribed among other things Tab Valicir 1gm tds for 7 days

analyse_media
analyse_media
analyse_media
Reading File
Finding Sources
Finding Sources
Searching the Web

valaciclovir valacyclovir drug reaction skin rash fixed drug eruption lichenoid

I now have a thorough picture. Here is the full clinical analysis:

Clinical Analysis: Skin Reaction Following Valaciclovir (Valicir 1g TDS) for Herpes

Image Findings (Visual Analysis Summary)

All three images show the forearm and antecubital fossa with:
  • Diffuse erythema with a mottled/reticulate pattern - pinkish-red to dusky violaceous hue
  • Ill-defined, irregular borders - patches that blend gradually into normal skin
  • Lichenification with exaggerated skin markings in the antecubital crease (chronic scratching/rubbing)
  • Post-inflammatory hyperpigmentation - brownish-dusky discoloration suggesting a subacute-to-chronic process
  • Scaling and desquamation distally near the wrist
  • Linear excoriations consistent with significant pruritus
  • A distinct violaceous/darker circular patch on the mid-forearm (Image 2) - this is particularly notable
  • No vesicles, no urticaria, no maculopapular discrete lesions

Clinical Assessment

Given the context of Valaciclovir (Valicir 1g TDS x 7 days) for herpes, this eruption most likely represents one or more of:

1. Fixed Drug Eruption (FDE) - Most Likely for the Circular Violaceous Patch

The single distinct dark violaceous/hyperpigmented circular macule on the mid-forearm in Image 2 is highly characteristic of a fixed drug eruption (FDE).
  • FDE is a well-documented adverse reaction to valacyclovir - a 2023 case report (PMC case report) documented a patient with recurrent localized brownish-erythematous macules on the same site each time valacyclovir was taken, confirmed by histopathology (vacuolar degeneration at dermoepidermal junction, pigmentary incontinence, perivascular inflammation).
  • FDE involves Type IV hypersensitivity - memory CD8+ T-cells at the dermoepidermal junction release IFN-γ, causing basal layer keratinocyte damage and melanocyte destruction, leaving the characteristic post-inflammatory hyperpigmentation.
  • Notably, the cited case showed no cross-reactivity to acyclovir, meaning switching to oral acyclovir is a safe alternative.

2. Morbilliform/Exanthematous Drug Rash - For the Diffuse Erythema

The widespread erythematous, ill-defined patches extending up the forearm may represent a morbilliform (drug hypersensitivity) rash, which is one of the most common cutaneous adverse drug reactions. This is also a recognized reaction to valacyclovir.

3. DRESS Syndrome - Must Be Excluded

Valacyclovir has been reported to cause DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms). This is a potentially serious reaction that typically develops 2-6 weeks after drug initiation and includes:
  • Diffuse exanthematous/urticarial rash on face, trunk, extremities
  • Fever, lymphadenopathy
  • Eosinophilia (CBC with differential needed)
  • Visceral involvement (elevated LFTs, creatinine)
This must be excluded clinically and with labs before dismissing as simple FDE.

4. Background Atopic Dermatitis / Eczema (Pre-existing)

The lichenification in the antecubital fossa, the flexural distribution, and scaling at the wrist suggest possible pre-existing atopic/eczematous dermatitis that may have been aggravated or is a confounding finding.

Recommended Management

StepAction
1. Stop Valaciclovir immediatelyValicir is the most likely causative agent - discontinue now
2. CBC with differentialCheck for eosinophilia (if >10% or >0.5x10⁹/L → raises concern for DRESS)
3. LFTs, RFTs, CRPAssess for visceral involvement to rule out DRESS/DIHS
4. Switch antiviral if neededOral acyclovir (400mg 5x/day or 800mg TDS) - no cross-reactivity documented in FDE cases
5. Topical corticosteroidsMid-potency (betamethasone valerate 0.1% or mometasone) for active inflammation
6. Oral antihistamineCetirizine or levocetrizine for pruritus
7. EmollientsFor lichenified/eczematous component
8. Dermatology referralFor formal patch testing to confirm FDE vs other diagnosis, and to document the reaction
9. DocumentationRecord valaciclovir as a suspected drug allergen in the patient's notes

Key Point

The violaceous hyperpigmented patch is the most clinically distinctive feature here - this is a hallmark of Fixed Drug Eruption to Valaciclovir, a recognized but relatively uncommon reaction. The diffuse erythema and lichenification may represent a co-existent drug rash or pre-existing eczema. The priority is to rule out DRESS with basic blood work, then manage symptomatically while switching to acyclovir for continued antiviral therapy.
⚠️ If the patient develops fever, facial oedema, lymphadenopathy, or feels systemically unwell - treat as DRESS and refer urgently.
attachment
attachment

She was diagnosed with herpes and the images i uploaded were after taking the me divination which gradually improved her condition. The picture I’ve uploaded now is how the condition is at the moment feels like it has worsened so what to do now. Should the course of antiviral be started again

analyse_media
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
I now have sufficient information for a thorough, structured answer. Here is the complete clinical assessment:

Current Image Analysis (New Photo - "Worsened" State)

What the Image Shows

Comparing to the previous images, the new photo shows:
FeaturePrevious ImagesCurrent Image
Vesicles/blistersAbsentStill absent
Active erosionsAbsentAbsent
CrustingMinimalAbsent
ErythemaModerate, mottledPersistent, dusky-violaceous
ScalingMildProminent grayish-white scaling throughout
LichenificationMild-moderateMarkedly increased - thickened plaques, exaggerated skin lines
DistributionForearm + antecubitalEntire volar forearm, more confluent
ColorPinkish-redDeeper violaceous/hyperpigmented - more post-inflammatory change
Key finding: There are no active herpetic lesions in the new image. No grouped vesicles, no dermatomal clustering, no fresh erosions or crusting - all of which would be expected with an active herpes recurrence.

What This Represents

This is NOT a herpes recurrence.

The current appearance is Lichen Simplex Chronicus (LSC) / Post-inflammatory Lichenified Eczema - a chronic scratch-itch cycle that has been triggered and perpetuated by:
  1. The original herpetic skin irritation/inflammation
  2. Subsequent scratching during and after the herpes episode
  3. Possibly aggravated by the prior drug reaction to Valaciclovir
The worsening appearance is due to progressive lichenification from ongoing pruritus and scratching - the more she scratches, the thicker and more inflamed the skin becomes, which makes it itch more. This is the classic itch-scratch cycle. This explains why it "looks worse" even though the herpes has resolved.

Should the Antiviral Course Be Restarted?

No, restarting Valaciclovir is not indicated at this time.
Reasons:
  • There are no active herpetic vesicles or erosions to treat
  • The completed 7-day course (1g TDS) was the appropriate treatment for the primary/recurrent herpes episode
  • The current skin changes are purely post-inflammatory/eczematous in nature, not viral
  • Valaciclovir previously caused a likely fixed drug eruption (the violaceous patch seen earlier) - restarting it risks triggering that reaction again in the same site
When antivirals WOULD be restarted: Only if she develops new grouped, painful vesicles on an erythematous base with burning/tingling prodrome (typical herpes recurrence). In that case, use oral Acyclovir 400mg 5 times daily for 5 days (not Valaciclovir, given the prior drug reaction).

Treatment Plan for Current Condition

1. Break the Itch-Scratch Cycle (Priority)

DrugDosePurpose
Cetirizine 10mg or Fexofenadine 180mgOnce daily at nightAnti-pruritic; sedating effect at night reduces nocturnal scratching
Hydroxyzine 25mgAt nightStronger sedating antihistamine if itch is severe

2. Anti-inflammatory (Topical)

DrugApplication
Mometasone furoate 0.1% cream or Betamethasone valerate 0.1%Once daily to the lichenified plaques for 2-3 weeks - reduces inflammation and breaks the itch cycle
Clobetasol propionate 0.05%Only for the most thickened/lichenified areas - short term (1 week), then step down

3. Emollients / Barrier Repair

  • Heavy emollient (petroleum jelly / white soft paraffin, or a fragrance-free cream like Cetaphil/CeraVe) applied generously 2-3 times daily
  • Apply immediately after bathing while skin is slightly damp
  • This reduces dryness and the itch that triggers scratching

4. Prevent Scratching

  • Keep nails trimmed short
  • Cotton gloves at night if nocturnal scratching is a problem
  • Avoid hot water, synthetic fabrics against the skin

5. Follow-up

  • Review in 2-3 weeks
  • If no improvement with topical steroids, consider tacrolimus 0.1% ointment (calcineurin inhibitor) or intralesional triamcinolone for stubborn lichenified plaques
  • Dermatology referral if not responding within 4-6 weeks

Summary

The current worsening appearance is Lichen Simplex Chronicus from a chronic itch-scratch cycle - NOT active herpes. Do not restart Valaciclovir. Treat with potent topical corticosteroids, antihistamines (especially at night), and intensive emollients. Herpes antivirals (if ever needed again) should be acyclovir, not valaciclovir, given the previous drug reaction.
This is a shared conversation. Sign in to Orris to start your own chat.